{
    "nctId": "NCT02416336",
    "briefTitle": "Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes",
    "officialTitle": "Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes",
    "overallStatus": "COMPLETED",
    "conditions": "Melanoma, Head and Neck Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "The percentage of patients for whom Sentinella detects additional tumor-positive SLNs.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All melanoma patients, with a Breslow thickness \\>1mm, who are seen at CPMC for sentinel node biopsy will be eligible to participate in this study provided that they have given consent.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}